Monitoring neutrophil-to-lymphocyte ratio in patients with coronavirus disease 2019 receiving tocilizumab
- PMID: 33387615
- PMCID: PMC7834747
- DOI: 10.1016/j.anai.2020.12.014
Monitoring neutrophil-to-lymphocyte ratio in patients with coronavirus disease 2019 receiving tocilizumab
References
-
- Hwang S.Y., Shin T.G., Jo I.J. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically ill septic patients. Am J Emerg Med. 2017;35(2):234–239. - PubMed
-
- Morrissey S.M., Geller A.E., Hu X. Emergence of low-density inflammatory neutrophils correlates with hypercoagulable state and disease severity in COVID-19 patients. https://www.medrxiv.org/content/10.1101/2020.05.22.20106724v1 - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
